These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9835393)

  • 1. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior.
    Steiner H; Gerfen CR
    Exp Brain Res; 1998 Nov; 123(1-2):60-76. PubMed ID: 9835393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons.
    Steiner H; Gerfen CR
    Neuroscience; 1999; 88(3):795-810. PubMed ID: 10363818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M; Besson MJ
    Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
    Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
    Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.
    Nylander I; Terenius LH
    Neuropharmacology; 1987 Sep; 26(9):1295-302. PubMed ID: 2444900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R; Gaudreau P; Martel JC; St-Pierre S; Zamir N
    Brain Res; 1985 Apr; 331(2):358-62. PubMed ID: 2859094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.
    Steiner H; Gerfen CR
    J Comp Neurol; 1995 Mar; 353(2):200-12. PubMed ID: 7745131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
    Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
    J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus.
    Maneuf YP; Mitchell IJ; Crossman AR; Brotchie JM
    Exp Neurol; 1994 Jan; 125(1):65-71. PubMed ID: 8307125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling.
    Deng YP; Lei WL; Reiner A
    J Chem Neuroanat; 2006 Dec; 32(2-4):101-16. PubMed ID: 16914290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
    Carta AR; Pinna A; Cauli O; Morelli M
    Synapse; 2002 Jun; 44(3):166-74. PubMed ID: 11954048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
    You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
    Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.
    Carta AR; Tronci E; Pinna A; Morelli M
    Eur J Neurosci; 2005 Mar; 21(5):1196-204. PubMed ID: 15813929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens.
    Angulo JA; McEwen BS
    Brain Res Brain Res Rev; 1994 Jan; 19(1):1-28. PubMed ID: 7909470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis.
    Manier M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1991; 42(2):427-39. PubMed ID: 1896133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic regulation of striatal efferent pathways.
    Surmeier DJ; Kitai ST
    Curr Opin Neurobiol; 1994 Dec; 4(6):915-9. PubMed ID: 7888777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons.
    Robertson GS; Vincent SR; Fibiger HC
    Neuroscience; 1992 Jul; 49(2):285-96. PubMed ID: 1359451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin.
    Besson MJ; Graybiel AM; Quinn B
    Neuroscience; 1990; 39(1):33-58. PubMed ID: 1708467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.